Answers are grounded in this paper and cite their sources.
This study describes surgical and quality of life outcomes in patients with peritoneal malignancy treated by cytoreductive surgery (CRS) alone compared with a subgroup treated with CRS and hyperthermic intraperitoneal chemotherapy (HIPEC).
No takes yet. Share an insight, caveat, or question.
Steffens et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: